|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.030 USD | +6.35% |
|
-3.70% | +76.63% |
| 07-14 | Cumberland Pharmaceuticals Inc. announces an Equity Buyback for $5 million worth of its shares. | CI |
| 07-13 | Cumberland Pharmaceuticals Announces Special Dividend, Payable on July 31, 2026 | CI |
| Market Cap | 99.04M 87.06M 81.05M 74.43M 140M 9.5B 142M 963M 376M 4.69B 372M 364M 16.21B | P/E 2024 |
-5.14x | P/E 2025 | -20.8x |
|---|---|---|---|---|---|
| Enterprise Value | 97.77M 85.95M 80.01M 73.48M 138M 9.38B 140M 951M 371M 4.63B 367M 359M 16B | EV / Sales 2024 |
0.95x | EV / Sales 2025 | 1.31x |
| Free-Float |
57.09% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cumberland Pharmaceuticals Inc.
| 1 day | +6.35% | ||
| 1 week | -3.70% | ||
| Current month | +8.49% | ||
| 1 month | +2.78% | ||
| 3 months | +67.78% | ||
| 6 months | +87.97% | ||
| Current year | +76.63% |
| 1 week | 5.75 |  | 8.06 |
| 1 month | 5.75 | | 8.09 |
| Current year | 2.69 | | 8.09 |
| 1 year | 1.85 | | 8.09 |
| 3 years | 1.04 | | 8.09 |
| 5 years | 1.04 | | 8.09 |
| 10 years | 0 | | 8.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 67 | 07/01/1999 |
John Hamm
DFI | Director of Finance/CFO | 70 | 17/05/2021 |
Shayla Simpson
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CHM | Chairman | 67 | 07/01/1999 |
| Director/Board Member | 74 | 10/09/2010 | |
James Jones
BRD | Director/Board Member | 78 | 01/01/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/18/26 A | Free | Responsable ventes & marketing | 3,000 | 0.0201% | ||
| 3/18/26 A | Free | Executive/Senior Manager | 3,000 | 0.0201% | ||
| 3/18/26 A | Free | Director | 1,800 | 0.0120% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.35% | -3.70% | +102.01% | +359.48% | 99.04M | |
| +0.13% | +4.41% | +48.19% | +163.20% | 1,067B | |
| +0.97% | +6.88% | +60.00% | +53.12% | 635B | |
| -0.94% | +1.39% | +36.28% | +72.60% | 458B | |
| +1.41% | +7.75% | +38.93% | +32.88% | 347B | |
| +1.28% | +2.82% | +38.42% | +43.21% | 295B | |
| +1.72% | +2.33% | +19.31% | +20.79% | 262B | |
| +1.84% | -1.03% | -27.78% | -38.45% | 216B | |
| +0.06% | +3.32% | +24.88% | +59.40% | 203B | |
| +0.94% | -2.02% | +15.47% | +70.59% | 161B | |
| Average | +1.72% | +0.86% | +35.57% | +83.68% | 364.36B | |
| Weighted average by Cap. | +0.89% | +1.95% | +37.76% | +78.43% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 37.87M 33.29M 30.99M 28.46M 53.44M 3.63B 54.14M 368M 144M 1.79B 142M 139M 6.2B | 44.52M 39.14M 36.43M 33.46M 62.83M 4.27B 63.66M 433M 169M 2.11B 167M 164M 7.29B |
| Net income | -6.48M -5.7M -5.3M -4.87M -9.14M -621M -9.26M -63.03M -24.62M -307M -24.32M -23.8M -1.06B | -2.84M -2.49M -2.32M -2.13M -4M -272M -4.06M -27.59M -10.77M -134M -10.65M -10.42M -464M |
| Net Debt | 2.61M 2.29M 2.13M 1.96M 3.68M 250M 3.73M 25.37M 9.91M 124M 9.79M 9.58M 427M | -1.26M -1.11M -1.03M -950K -1.78M -121M -1.81M -12.3M -4.8M -59.87M -4.75M -4.64M -207M |
Employees
93
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/07/26 | $7.030 | +6.35% | 72,339 |
| 24/07/26 | $6.610 | -5.37% | 123,409 |
| 23/07/26 | $6.985 | -1.83% | 419,000 |
| 22/07/26 | $7.115 | -9.36% | 147,811 |
| 21/07/26 | $7.850 | +7.53% | 137,146 |
- Stock Market
- Stocks
- CPIX Stock
Select your edition
All financial news and data tailored to specific country editions
